SELENOV and gastric cancer: Low expression of SELENOV is associated with poor prognosis of gastric cancer, its enhancement can inhibit cancer, and its antioxidant and anti‐ER stress mechanisms may be universally applicable to multiple cancer types (Zhang et al. 2020; Lan et al. 2017)